Question 1

What is the catalog number for Human ELFN2 Knockout A549 cell line?

Accepted Answer

The catalog number for Human ELFN2 Knockout A549 cell line is A549KO-12709.

Question 2

What sizes are available for Human ELFN2 Knockout A549 cell line?

Accepted Answer

Human ELFN2 Knockout A549 cell line is available in the following size(s): 1 Vial.

Question 3

Is Human ELFN2 Knockout A549 cell line in stock?

Accepted Answer

Human ELFN2 Knockout A549 cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Human ELFN2 Knockout A549 cell line used for?

Accepted Answer

Engineered clonal A549 cells with ELFN2 gene knockout, sequence confirmed.

Question 5

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Human ELFN2 Knockout A549 cell line

Product Specifications

Frequently Asked Questions

Explore Other Products

Recombinant Human Hexokinase-3/HK3 Protein (His & GST Tag)

MGEA5 Recombinant Rabbit Monoclonal Antibody [JG40-05]

Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1992), CF568 conjugate, 0.1mg/mL

Recombinant Rat ALK-2/ACVR1 Protein (Fc Tag)

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/2052R), CF640R conjugate, 0.1mg/mL

Small Cell Lung Cancer (SCLC) (MOC-52), CF640R conjugate, 0.1mg/mL